BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24461384)

  • 21. A Delphi exercise and cluster analysis to aid in the development of potential classification criteria for systemic sclerosis using SSc experts and databases.
    Coulter C; Baron M; Pope JE
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):24-30. PubMed ID: 23557780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels.
    Vettori S; Cuomo G; Iudici M; D'Abrosca V; Giacco V; Barra G; De Palma R; Valentini G
    J Clin Immunol; 2014 Aug; 34(6):663-8. PubMed ID: 24760110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Scleroderma associated autoantibodies - clinical and diagnostic relevance].
    Mierau R; Genth E
    Z Rheumatol; 2006 Jul; 65(4):279-84. PubMed ID: 16788839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the 2013 American College of Rheumatology/European League Against Rheumatism classification criteria for systemic sclerosis in patients from a capillaroscopy clinic.
    Melchor S; Joven BE; Andreu JL; Loza E; Garcia de Yebenes MJ; Carmona L; Carreira PE
    Semin Arthritis Rheum; 2016 Dec; 46(3):350-355. PubMed ID: 27373498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
    Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C
    Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nailfold capillaroscopy in primary biliary cirrhosis: a useful tool for the early diagnosis of scleroderma.
    Tovoli F; Granito A; Giampaolo L; Frisoni M; Volta U; Fusconi M; Masi C; Lenzi M
    J Gastrointestin Liver Dis; 2014 Mar; 23(1):39-43. PubMed ID: 24689095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical features of systemic sclerosis and association with antitopoisomerase-1 antibody and centromere pattern of antinuclear antibody].
    Bertazzi GR; de Toledo RA; de Godoy MF; Geraldino GC; Polizelli DV; Fernandes GC; Pedroso CL; dos Santos FG; de Assis TM
    Acta Reumatol Port; 2012; 37(1):9-17. PubMed ID: 22781510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The concept of early systemic sclerosis following 2013 ACR\EULAR criteria for the classification of systemic sclerosis.
    Valentini G; Marcoccia A; Cuomo G; Iudici M; Vettori S
    Curr Rheumatol Rev; 2014; 10(1):38-44. PubMed ID: 24720644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database.
    Schneeberger D; Tyndall A; Kay J; Søndergaard KH; Carreira PE; Morgiel E; Deuschle K; Derk CT; Widuchowska M; Walker UA
    Rheumatology (Oxford); 2013 Mar; 52(3):560-7. PubMed ID: 23221323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.
    Faucher B; Stein P; Granel B; Weiller PJ; Disdier P; Serratrice J; Harlé JR; Durand JM; Frances Y; Guis S; Pham T; Bardin N; Sanmarco M
    Eur J Intern Med; 2010 Apr; 21(2):114-7. PubMed ID: 20206882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From Raynaud's Phenomenon to Very Early Diagnosis of Systemic Sclerosis- The VEDOSS approach.
    Bellando-Randone S; Matucci-Cerinic M
    Curr Rheumatol Rev; 2013; 9(4):245-8. PubMed ID: 26932288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy.
    Matucci-Cerinic M; Allanore Y; Czirják L; Tyndall A; Müller-Ladner U; Denton C; Valentini G; Distler O; Fligelstone K; Tyrrel-Kennedy A; Farge D; Kowal-Bielecka O; van den Hoogen F; Cutolo M; Sampaio-Barros PD; Nash P; Takehara K; Furst DE
    Ann Rheum Dis; 2009 Sep; 68(9):1377-80. PubMed ID: 19674983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort.
    Trapiella-Martínez L; Díaz-López JB; Caminal-Montero L; Tolosa-Vilella C; Guillén-Del Castillo A; Colunga-Argüelles D; Rubio-Rivas M; Iniesta-Arandia N; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas-Hitos JA; Ríos-Blanco JJ; Todolí-Parra JA; Rodríguez-Carballeira M; Marín-Ballvé A; Chamorro-Fernández AJ; Pla-Salas X; Madroñero-Vuelta AB; Ruiz-Muñóz M; Fonollosa-Pla V; Simeón-Aznar CP;
    Autoimmun Rev; 2017 Aug; 16(8):796-802. PubMed ID: 28564618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
    Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
    Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Very early systemic sclerosis.
    Bellando-Randone S; Matucci-Cerinic M
    Best Pract Res Clin Rheumatol; 2019 Aug; 33(4):101428. PubMed ID: 31810547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology?
    Cutolo M; Smith V
    Rheumatology (Oxford); 2013 Nov; 52(11):1933-40. PubMed ID: 23620555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification of Japanese patients with mild/early systemic sclerosis (SSc) by the 2013 ACR/EULAR classification criteria for SSc.
    Ikawa Y; Hamaguchi Y; Mugii N; Matsushita T; Takehara K
    Mod Rheumatol; 2017 Jul; 27(4):614-617. PubMed ID: 27830961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.
    Shen CY; Li KJ; Lai PH; Yu CL; Hsieh SC
    Clin Rheumatol; 2018 Mar; 37(3):749-756. PubMed ID: 28940121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.
    D'Aoust J; Hudson M; Tatibouet S; Wick J; ; Mahler M; Baron M; Fritzler MJ
    Arthritis Rheumatol; 2014 Jun; 66(6):1608-15. PubMed ID: 24577935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.